Adamantinomatous Craniopharyngioma Clinical Trials

1 clinical trials found for Adamantinomatous Craniopharyngioma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Adamantinomatous Craniopharyngioma

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (Tocilizumab) for the Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

NCT05233397 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Adamantinomatous Craniopharyngioma?

There are 1 clinical trials listed for Adamantinomatous Craniopharyngioma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Adamantinomatous Craniopharyngioma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Adamantinomatous Craniopharyngioma trials in?

Current Adamantinomatous Craniopharyngioma trials are distributed across: Phase 2 (1).

Find More Trials